Surface Ophthalmics, founded in 2017 and based in Pleasanton, California, is a pharmaceutical company focused on developing and commercializing innovative therapeutics for ocular diseases. Their proprietary drug candidates utilize Klarity, a patented delivery vehicle, to protect and rehabilitate the ocular surface. By providing topical formulations, Surface Ophthalmics enables medical practitioners to help patients combat dry eye diseases and associated conditions.